SCHEMBL9949899

SCHEMBL9949899

CCC(CO)NC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13741273 1.00
SCHEMBL13392137 1.00
SCHEMBL3353769 0.85 LMNA (0.60)
SCHEMBL2606746 0.85
SCHEMBL24946348 0.85 LMNA (0.40)
SCHEMBL4781355 0.83 LMNA (0.52)
SCHEMBL104880 0.82
SCHEMBL13741465 0.81
SCHEMBL2464426 0.81 TDP1 (0.50)
SCHEMBL1005605 0.81 LMNA (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873291-B2 Quinoline cGAS antagonist compounds IMMUNESENSOR THERAPEUTICS, INC. (US) 2024-01-16 US disclosed
US-20230357158-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2023-11-09 US disclosed
US-11713307-B2 Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases CHEMOCENTRYX, INC. (US) 2023-08-01 US disclosed
US-20230143470-A1 SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ NATIONAL INSTITUTES OF HEALTH 2023-05-11 US disclosed
US-20230143470-A1 SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ NATIONAL INSTITUTES OF HEALTH 2023-05-11 US disclosed
WO-2021121390-A1 HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF AND APPLICATION THEREOF 苏州信诺维医药科技股份有限公司 2021-06-24 WO disclosed
US-10519160-B2 Imaging agents for neural flux THE GENERAL HOSPITAL CORPORATION (US) 2019-12-31 US disclosed
EP-2782921-B1 ORGANIC TUNGSTEN COMPLEXES VANDERBILT CHEMICALS LLC (US) 2018-05-02 EP disclosed
US-9815916-B2 Polymers and DNA copolymer coatings ILLUMINA CAMBRIDGE LIMITED (GB) 2017-11-14 US disclosed
US-9416111-B2 Substituted diazine and triazine spleen tyrosine kinease (Syk) inhibitors MERCK SHARP & DOHME CORP. (US) 2016-08-16 US disclosed
WO-2015120730-A1 THIOCHROMENO[2,3-C]QUINOLIN-12-ONE DERIVATIVES, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 黄旭山 2015-08-20 WO disclosed
US-20150166486-A1 SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINEASE (SYK) INHIBITORS MERCK SHARP & DOHME LLC 2015-06-18 US disclosed
US-20150148327-A1 SUBSTITUTED PYRIDINE SPLEEN TYROSINE KINASE (SYK) INHIBITORS MERCK CANADA INC. (CA) 2015-05-28 US disclosed
US-8927717-B1 Thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2015-01-06 US disclosed
EP-2782921-A1 ORGANIC TUNGSTEN COMPLEXES Vanderbilt Chemicals, LLC (US) 2014-10-01 EP disclosed
CN-103958536-A Organic tungsten complexes VANDERBILT CHEMICALS LLC 2014-07-30 CN disclosed
US-8669386-B2 Organic tungsten complexes VANDEBILT CHEMICALS, LLC (US) 2014-03-11 US disclosed
WO-2013077948-A1 ORGANIC TUNGSTEN COMPLEXES VANDERBILT CHEMICALS, LLC. (US) 2013-05-30 WO disclosed
US-20120165563-A1 ORGANIC TUNGSTEN COMPLEXES R.T. VANDERBILT COMPANY, INC. 2012-06-28 US disclosed
US-4004025-A Long-acting local subcutaneously-applied anesthetics and compositions containing the same Lewenstein, Evalina (US) 1977-01-18 US disclosed